Showing 1111-1120 of 3001 results for "".
Diagnostic Considerations for New-Onset Epilepsy in Older Adults
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/diagnostic-considerations-for-new-onset-epilepsy-in-older-adults/32175/Early recognition and accurate diagnosis by health care providers are key to the optimal management of the older adult with epilepsy.Myasthenia Gravis Treatment
https://practicalneurology.com/diseases-diagnoses/neuromuscular/myasthenia-gravis-treatment/31553/Both symptomatic and maintenance treatments are available.Fibromuscular Dysplasia and Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/fibromuscular-dysplasia-and-stroke/31615/Stroke in fibromuscular dysplasia is associated with cervical artery dissection and can be managed with antiplatelet therapy and avoidance of high-risk cervical exertion.Tuberous Sclerosis Complex
https://practicalneurology.com/diseases-diagnoses/child-neurology/tuberous-sclerosis-complex/31942/Tuberous sclerosis complex represents the opportunity of targeted treatment resulting from identifying pathogenic gene variants for long-recognized syndromes.Microplastics and "Negative Neuroplasticity": An Emerging Topic in Clinical Neurology
https://practicalneurology.com/columns/practice-management/microplastics-and-negative-neuroplasticity/39811/Microplastics are neurotoxic in nature and can enter and accumulate in the brain, raising many questions concerning their role in common neurologic illnesses.Rise of the Genomic Medicine Era in Amyotrophic Lateral Sclerosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/rise-of-the-genomic-medicine-era-in-amyotrophic-lateral-sclerosis/32024/Advances in gene-targeted therapies are positioned to transform clinical treatment for familial and sporadic amyotrophic lateral sclerosis.Spinal Muscular Atrophy is Now a Treatable Genetic Condition
https://practicalneurology.com/diseases-diagnoses/neuromuscular/spinal-muscular-atrophy-is-now-a-treatable-genetic-condition/32025/Multiple therapy options are available for the treatment of people with spinal muscular atrophy, a genetic disorder presenting with a wide range of symptoms and severity.Digital Biomarkers in Neuromuscular Disorders: Recent Advances
https://practicalneurology.com/diseases-diagnoses/neuromuscular/digital-biomarkers-in-neuromuscular-disorders-recent-advances/35556/Digital health technologies have strong potential to aid in the study and management of neuromuscular conditions.Pharmacology of Emerging Selective Sodium Channel Antagonists for the Treatment of Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pharmacology-of-emerging-selective-sodium-channel-antagonists-for-the-treatment-of-epilepsy/39904/The development of isoform-selective sodium channel inhibitors that spare GABAergic interneuron function is in its early stages but holds promise as an exciting area of research.Stroke Snapshot: Reversible Cerebral Vasoconstriction Syndrome
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-snapshot-reversible-cerebral-vasoconstriction-syndrome/31820/Early correct diagnosis is imperative because RCVS presentations can overlap with diverse syndromes with disparate treatments.